← All Carlsmed, INC filings

Carlsmed, INC S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

NASDAQ
CARL
Carlsmed, INC
S-1/A: Carlsmed Files for IPO, Eyes 2026 Cervical Spine Market Expansion Amid Strong Revenue Growth
Carlsmed, a medical technology company specializing in AI-enabled personalized spine surgery, is pursuing an initial public offering of 6.7 million shares, aiming to raise approximately $88.3 million to fuel commercialization and R&D, particularly for its planned 2026 cervical spine fusion market entry.
NASDAQ
CARL
Carlsmed, INC
S-1: Carlsmed Files S-1 for IPO, Highlighting AI-Powered Personalized Spine Surgery and Strong Revenue Growth
Carlsmed, Inc., a medical technology company pioneering AI-enabled personalized spine surgery solutions, has filed its S-1 registration statement for an initial public offering, showcasing significant revenue growth and positive clinical outcomes for its aprevo Technology Platform.